Unicorn Capital Partners is a venture capital firm managing a newly raised fund of RUB 4.5 billion (~$65 million), co-invested by the Russian Government. The firm focuses on Series A and B investments in breakthrough therapeutics, diagnostics, devices, and medical IT sectors, targeting unmet medical needs within Russia.